Organization: MDS Proteomics Inc

MDS Proteomics teams with Agilent Technologies

Toronto’s MDS Proteomics Inc and Agilent Technologies Inc, Palo Alto CA, have entered an agreement to develop new protein analysis technologies and applications to accelerate the speed of medicine development. MDS will work with Agilent’s Bio-Consumables and Services division, which possesses expertise in separation science and liquid chromotography for identifying and characterizing proteins. MDS will…

MDS PROTEOMICS FORGES AHEAD WITH EXPANSIONS

MDS Proteomics Inc is continuing to increase its research capabilities despite its recent withdrawal of an initial public offering with the completion of a new facility in Odense Denmark and an expansion of Toronto facilities. The 3,000-sq-m Danish facility will house more than 60 scientists, several customized mass spectrometers and the world’s 11th largest cluster…

MDS Proteomics and IBM strike major collaboration

IBM Corp‘s Life Sciences Unit and MDS Proteomics Inc (MDSP) have entered into a multi-faceted collaboration that will see the two firms launch research projects and establish a publicly available bioinformatics database available to researchers worldwide. As part of the agreement, IBM will make an equity investment in MDSP and become a preferred supplier of…